Please assess the completion status of the following clinical trial:

Trial Title: Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male 40 years of age~* Clinical signs and symptoms of frequency and urgency, with or without UUI, with or without BOO, for at least three months~* Mean urinary frequency of 8 micturitions/24h verified by the Screening micturition diary~Exclusion Criteria:~* Post-void residual urine volume (PVR) of \> 200 ml as measured by an ultrasound~* Maximum urinary flow rate (Qmax) of \< 5 ml/second as measured by a flowmeter; a voided volume of 75 ml is required in order to accurately record the Qmax~* Prescribed and administered an antimuscarinic or antispasmodic within 1 month~* Prescribed and administered an a-1-adrenergic antagonist within 2 weeks

- Gender: MALE
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).